Contact UsInvestorsCareersMediaScienceContact Us
Home News

Media Enquiries

This route is intended for accredited journalists with a specific media enquiry.

If you are a journalist with a media enquiry, please email the Pfizer New Zealand Media Relations team at: [email protected]

We are unable to respond to non-media enquiries submitted via this route.


Media Releases

The following Media Releases are intended for journalists.


Pfizer to provide additional 40,000 PAXLOVID treatment courses in New Zealand to help combat COVID-19
2022.11.22COVID-19 summer checklist: How Kiwis can embrace their holiday season – survey2022.03.31Pfizer's novel COVID-19 oral treatment arrives in New Zealand2021.12.06Pfizer to Provide NZ with 60,000 Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-192020.09.12Pfizer and BioNTech to Supply New Zealand with their Vaccine Against COVID-19Recent Submissions on Important Issues to the Medicines Industry2023.03.03Therapeutic Products Bill NZ2022.06.11Medicines Amendment Bill
Your HealthAbout UsOur ScienceOur Products Partners Pfizer Worldwide Terms & Conditions - Suppliers Pfizer Anti-bribery & Anti-corruption Principles Terms & Conditions - Customers Grant Seekers Media TransparencyCollaborationHealthcare ProfessionalsPrivacy Policy  Contact Us Terms Of Use  Business to Business
Copyright © 2022 Pfizer New Zealand Limited. All rights reserved. Last updated May 27 2022. PP-UNP-NZL-0002 06/22. TAPS NP18187